Related Experiment Video

Updated: Apr 20, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

The Facilitators of and Barriers to Adherence to Hypertension Treatment Scale

Marie N Fongwa1, Karabi Nandy, Qing Yang

  • 1Marie N. Fongwa, PhD, RN, MPH Associate Professor, School of Nursing, Azusa Pacific University, California. Karabi Nandy, PhD Assistant Adjunct Professor, School of Nursing and Department of Biostatistics, University of California, Los Angeles. Qing Yang, PhD Assistant Research Professor, School of Nursing, Duke University, Durham, North Carolina. Ron D. Hays, PhD Professor of Medicine, Department of Medicine, University of California, Los Angeles.

The Journal of Cardiovascular Nursing
|November 25, 2014
PubMed

Insights

A new scale, the Facilitators of and Barriers to Adherence to Hypertension Treatment Scale (FATS), was developed to help improve high blood pressure control in African American women.

Area of Science:

  • Cardiovascular Health
  • Health Disparities
  • Psychometrics

Background:

  • Adherence to hypertension treatment is crucial for blood pressure control, especially in African American (AA) women who experience significant disparities.
  • Existing measures may not adequately capture cultural nuances affecting adherence in this population.
  • A culturally sensitive tool is needed to identify facilitators and barriers to hypertension management.

Purpose of the Study:

  • To develop and validate the Facilitators of and Barriers to Adherence to Hypertension Treatment Scale (FATS).
  • To create a culturally sensitive instrument for assessing adherence factors in AA women with high blood pressure (HBP).

Main Methods:

  • Focus groups with 20 AA women informed the development of the FATS.
  • The 18-item FATS was administered to 147 AA women in Los Angeles.
  • Internal consistency reliability was assessed using Cronbach's alpha.

Main Results:

  • The FATS demonstrated good internal consistency with a Cronbach's alpha of .78.
  • The FATS score was significantly associated with the Hill-Bone High Blood Pressure Compliance Scale (β = .35, P = .0014).
  • FATS scores also correlated with social support (β = .42, P = .001) and alcohol use screening (β = -.24, P = .05).

Conclusions:

  • The FATS is a culturally sensitive and reliable measure for assessing adherence facilitators and barriers in AA women with HBP.
  • Further validation in diverse AA women populations is recommended.
  • The FATS can aid in developing targeted interventions to improve hypertension treatment adherence.
Abstract

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
666
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
956
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.9K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
817
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.9K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614